SHC
SHC
US83601L1026
Sotera Health Company
Loading chart...

Company Profile

Sotera Health Company provides sterilization solutions, lab testing, and advisory services for the healthcare industry in the United States, Canada, Europe, and internationally. The company operates through three segments: Sterigenics, Nordion, and Nelson Labs. The Sterigenics segment offers outsourced terminal sterilization and irradiation services using gamma irradiation, ethylene oxide processing, and electron beam irradiation technologies for medical devices, pharmaceutical, and food safety and advanced applications markets. The Nordion segment provides Cobalt-60 used in the sterilization and irradiation processes for the medical device, pharmaceutical, food safety, and high-performance materials industries, as well as in the treatment of cancer. It also offers gamma irradiation systems. The Nelson Labs segment provides outsourced microbiological and analytical chemistry testing and advisory services for the medical device and pharmaceutical industries. The company was formerly known as Sotera Health Topco, Inc. and changed its name to Sotera Health Company in October 2020. Sotera Health Company was incorporated in 2015 and is headquartered in Broadview Heights, Ohio.

Latest News

Related stocks

BLLN
BLLN • United States
BillionToOne, Inc.
98.09 USD
4.63B USD
VCYT
VCYT • United States
Veracyte, Inc.
45.23 USD
3.64B USD 1Y +24.2%
ADPT
ADPT • United States
Adaptive Biotechnologies Corpor
26.49 USD
4.23B USD 1Y +67.8%
RDNT
RDNT • United States
RadNet, Inc.
70.91 USD
5.58B USD 1Y -10.3%
NEO
NEO • United States
NeoGenomics, Inc.
16.35 USD
2.13B USD 1Y +74.7%
WGS
WGS • United States
GeneDx Holdings Corp.
67.33 USD
2.01B USD 1Y -44.8%
CDNA
CDNA • United States
CareDx, Inc.
63.67 USD
3.29B USD 1Y +320.6%
GRAL
GRAL • United States
GRAIL, Inc.
140.58 USD
6.28B USD 1Y +82.2%

Key Metrics & Overview

Detailed metrics & financial data of the company

Company Profile
5 Metrics

🛡️ Risk & Structural Analysis

Multi-Factor Risk Model & Market Data

7/7 Very High
5Y Volatility
64.8% p.a.
Max Drawdown (5Y)
-78.2%
Sharpe Ratio (5Y)
-0.15
Beta Factor
1.85
Size Class
Mid Cap
Notes & Warnings
Single Stock Risk: Investing in an individual stock carries full company and insolvency risk (no fund diversification).
Critical leverage: Debt-to-Equity is at 341%.
High market risk: Beta of 1.85 indicates above-average volatility compared to the broader market.
Structurally High Volatility: Above-average fluctuations persist across 5 to 10 years (64.8% p.a.).
Historical Stress Test: Maximum peak-to-trough drawdown of -78.2% in the extended horizon.
ende